Home
About Us
Company Profile
HIstory
Culture
Honor
Products
Cardiovascular series
Psychiatry series
Hepatobiliary, Gastroenterology Series
Respiratory series
Anti-infective virus series
Other series
Large Infusion Series
Huabao Tong Series
Active Pharmaceutical Ingredient Series
R&D
Academician Expert Workstation
Medical Research and Industry Alliance
News
General News
Party group dynamics
Employee activity
HR
Talent Strategy
Company recruitment
Contact us
中文版
Date:
29 Aug,2022
5 Month, Acquiring Tangshan Bohai Pharmaceutical Co., Ltd.
Previous page
2009
2004
Next page
Related Recommendations
2021/03/01
A delegation led by Li Yunlong, Executive Vice President of the China Association for Pharmaceutical Regulatory Research, visited and inspected Wanbangde Pharmaceutical Group.
Chairman Zhao Shouming inspects the development of Hangzhou's distinctive towns.
The World Federation of Chinese Medicine Geriatrics Annual Conference Held; Wanbangde Products Receive Positive Feedback